RUMORED BUZZ ON ABBV-744 FOR SMALL CELL LUNG CANCER RESEARCH

In Section A, individuals will receive distinctive doses and schedules of oral ABBV-744 pill to discover Protected dosing regimen. More members might be enrolled with the recognized monotherapy dosign program. In Section B, participants will get oral ruxolitinib and ABBV-744 will likely be offered as "increase-on" therapy. In Section C, participant